Matt Tegtmeyer

Matt Tegtmeyer has a diverse work experience in the field of biosciences and neuroscience research. Matt started their career as a Graduate Student Researcher at Cincinnati Children's Hospital Medical Center in 2015. Matt then joined the Institute of Psychiatry, Psychology, and Neuroscience in 2016 as a Graduate Student, where they focused on researching the cellular and molecular mechanisms of behavioral and psychiatric disorders. In this role, they also explored the efficacy of using induced-pluripotent stem cells (iPSCs) for modeling disorders of the CNS. In 2017, Matt took on the role of Research Assistant at the Institute, and they continued this position until 2020.

During this time, Matt also expanded their experience by working as a Visiting Scholar at both the Broad Institute of MIT and Harvard and Harvard University. At the Broad Institute, they held the role of Research Associate from 2017 to 2019, while at Harvard University, they worked as a Visiting Scholar from 2017 to present, as well as a Teaching Fellow starting from 2019.

Matt'smost recent work experience includes joining Q-State Biosciences in 2018 as a Scientist, and in 2020, they became the Regional Coordinator at the National Scientist Volunteer Database. Overall, Matt Tegtmeyer's work experience demonstrates their expertise and dedication to biosciences and neuroscience research.

Matt Tegtmeyer completed their education in a chronological order. First, from 2010 to 2014, they attended Miami University, where they obtained an Associate of Science (A.S.) degree in Political Science and Government. Following this, from 2011 to 2014, they pursued a Bachelor of Science (B.S.) degree in Kinesiology and Exercise Science at the same institution.

Continuing their academic journey, Tegtmeyer attended King's College London from 2016 to 2018. During this period, they completed a Master of Science (MSc) program in Neuroscience, focusing on Neural Stem Cell and Nervous System Repair Research. Building upon this foundation, they then embarked on a Doctor of Philosophy (PhD) program at King's College London in 2019. Intensively studying Genetics and Molecular Medicine, Tegtmeyer is expected to complete their PhD in 2023.